|
Chronic heart failure patients with high collagen type I degradation marker levels benefit more with ACE-inhibitor therapy. |
|
|
|
|
Συντάχθηκε απο τον/την gkatsaros
|
|
Τρίτη, 01 Δεκέμβριος 2009 00:00 |
|
Chronic heart failure patients with high collagen type I degradation marker levels benefit more with ACE-inhibitor therapy.
Chatzikyriakou SV, Tziakas DN, Chalikias GK, Stakos D, Thomaidi A, Mitrousi K, Boudoulas H.
Eur J Pharmacol. 2010 Feb 25;628(1-3):164-70. Epub 2009 Dec 1.
|
|
Τελευταία Ενημέρωση στις Τετάρτη, 10 Φεβρουάριος 2010 17:27 |